Healthcare payments company Waystar said on Tuesday it was targeting a valuation of up to $3.83 billion in its initial public offering in the United States, joining a clutch of companies looking to tap into improving investor appetite for new listings. The U.S. IPO market is on a rebound in 2024, after two sub-par years amid increasing hopes of a soft landing for the economy and rate cuts by the Federal Reserve in the second half of the year. Louisville, Kentucky-based Waystar was formed in 2017 through the merger of Navicure and ZirMed. The company develops payments software that helps clients such as large hospital systems to manage their finances.
Read the full article: Healthcare Payments Firm Waystar Aims up to $3.83B Valuation in US IPO //
Source: https://www.reuters.com/markets/deals/waystar-aims-up-383-bln-valuation-us-ipo-2024-05-28/